Financial Performance - The company's total operating revenue for Q3 2023 was RMB 4,776,130,289.37, representing a decrease of 0.72% compared to the same period last year[4]. - Net profit attributable to shareholders for the same period was RMB 1,271,602,434.56, an increase of 22.72% year-on-year[4]. - Basic and diluted earnings per share for Q3 2023 were both RMB 0.14, reflecting a 4.48% increase compared to the previous year[4]. - The total operating income for the current period is 18,013,657,311.89, compared to 17,515,059,218.08 in the previous period, representing an increase of approximately 2.85%[18]. - The net profit attributable to shareholders of the parent company is 5,810,008,111.11, compared to 5,234,292,110.40 in the previous period, reflecting an increase of approximately 10.96%[19]. - The total profit for the current period is 7,387,590,860.40, compared to 6,846,874,666.58 in the previous period, showing an increase of about 7.93%[18]. - The total comprehensive income for the current period is 7,079,541,473.20, compared to 6,254,572,214.64 in the previous period, representing an increase of about 13.16%[19]. Assets and Liabilities - Total assets as of September 30, 2023, amounted to RMB 66,891,778,766.67, an increase of 8.37% from the end of the previous year[4]. - The total assets as of September 30, 2023, amounted to ¥668.92 billion, an increase from ¥617.26 billion as of December 31, 2022, representing an 8.3% growth[14]. - The total liabilities as of September 30, 2023, were ¥529.63 billion, compared to ¥492.46 billion at the end of 2022, reflecting a 7.5% rise[16]. - The equity attributable to the parent company's shareholders increased to ¥134.48 billion from ¥120.15 billion, marking an increase of 11.9%[17]. - The company reported a total borrowing balance of ¥3,512.73 billion as of June 30, 2023, representing a 29.70% increase over the previous year's net assets[12]. Cash Flow - The net cash flow from operating activities decreased, while the net cash flow from financing activities improved, with a net outflow of ¥8,780,475,912.19 in 2023 compared to ¥15,151,120,641.85 in 2022[8]. - The net cash flow from operating activities is 12,427,006,624.21, down from 19,667,347,765.31 in the previous period, indicating a decrease of approximately 36.5%[20]. - The net cash flow from investment activities is -7,018,260,308.06, compared to -5,428,981,168.46 in the previous period, showing a worsening of approximately 29.3%[20]. - The net cash flow from financing activities was negative at ¥8.78 billion, compared to a negative ¥15.15 billion in the previous period, representing an improvement of approximately 42.5%[21]. - The ending cash and cash equivalents balance was ¥146.65 billion, an increase from ¥141.48 billion in the previous period, reflecting a growth of about 3.1%[21]. Shareholder Information - The total number of shares outstanding as of the last trading day before disclosure was 7,621,087,664[4]. - The total number of ordinary shareholders at the end of the reporting period was 215,460, with 214,000 being A-share shareholders[9]. - The top ten shareholders held significant stakes, with Jilin Aodong Pharmaceutical Group Co., Ltd. owning 16.43% and Liaoning Chengda Co., Ltd. holding 16.40%[10]. Other Financial Metrics - Investment income for the first three quarters of 2023 reached ¥3,421,421,290.10, a 62.28% increase compared to ¥2,108,391,475.71 in the same period of 2022[8]. - Fair value changes in financial assets showed a significant improvement, with a loss of ¥96,697,385.81 in 2023 compared to a loss of ¥1,770,416,721.26 in 2022[8]. - Other business income decreased by 80.57%, from ¥949,574,570.72 in 2022 to ¥184,470,357.20 in 2023, primarily due to reduced commodity sales[8]. - The company reported a warning and fines totaling ¥943,396.23 for business misconduct related to the underwriting services provided to Meishang Ecology[13]. - The company’s receivables decreased to ¥11.77 billion from ¥13.77 billion, a decline of 14.5%[14]. - The company’s financial investments reached ¥354.08 billion, up from ¥302.82 billion, indicating a 16.9% increase year-over-year[14].
广发证券(01776) - 2023 Q3 - 季度业绩